Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data
Author:
Affiliation:
1. Tokyo Medical University; Tokyo Japan
2. Hyogo College of Medicine; Nishinomiya Japan
3. Novo Nordisk Pharma Ltd.; Tokyo Japan
4. Nara Medical University; Kashihara Japan
Funder
Novo Nordisk
Toni Lappin of PAREXEL
Pfizer
Publisher
Wiley
Subject
Genetics (clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13033/fullpdf
Reference18 articles.
1. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A;Huth-Kühne;Haematologica,2009
2. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Center Doctors' Organisation;Collins;Blood,2007
3. A survey of acquired inhibitors of blood coagulation in Japan;Shima;Japanese J Thromb Haemost,2003
4. A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan - analysis of prognostic factors;Tanaka;Japanese J Thromb Haemost,2008
5. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2);Knoebl;J Thromb Haemost,2012
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies;Medicina;2023-09-28
2. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders;Annals of Hematology;2023-06-30
3. Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment;Diagnostics;2023-01-23
4. ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database;International Journal of Hematology;2022-11-04
5. Acquired Haemophilia A: A Review of What We Know;Journal of Blood Medicine;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3